Home › Funds › ARMISTICE CAPITAL, LLC › XRAY

ARMISTICE CAPITAL, LLC position in XRAY

DENTSPLY SIRONA INC · Health Care

ARMISTICE CAPITAL, LLC reported holding 3,672,000 shares of XRAY (DENTSPLY SIRONA INC) in its Q2 2026 13F filing — a position valued at US$39.0M, representing 0.51% of its reported portfolio and ranking #27 among its reported holdings. ARMISTICE CAPITAL, LLC has disclosed XRAY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.67M sh
Reported value held$38.96M
Portfolio Weight0.51%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ARMISTICE CAPITAL, LLC's XRAY position evolved

ARMISTICE CAPITAL, LLC first disclosed a stake in XRAY in Q3 2023 at 1,827,805 shares (US$62.4M). The position peaked in Q4 2025 at 7,298,000 shares, worth US$83.4M. Across 12 filings, ARMISTICE CAPITAL, LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,672,000 shares valued at US$39.0M — an increase of 672,000 shares quarter over quarter.. Notable position changes include a 83% trim in Q2 2025 (shares fell 20% over the following quarter), a 1044% increase in Q3 2025 (shares fell 10% over the following quarter), a 59% trim in Q1 2026 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.83M $62.44M New
Q4 2023 1.90M $67.48M Add
Q1 2024 1.75M $57.98M Reduce
Q2 2024 2.30M $57.24M Add
Q3 2024 2.65M $71.62M Add
Q4 2024 3.50M $66.42M Add
Q1 2025 3.00M $44.82M Reduce
Q2 2025 501.41K $7.96M Reduce
Q3 2025 5.74M $72.79M Add
Q4 2025 7.30M $83.42M Add
Q1 2026 3.00M $34.80M Reduce
Q2 2026 3.67M $38.96M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XRAY and 13F data

XRAY (DENTSPLY SIRONA INC) is a Health Care company. 13 other funds we track also report a position in XRAY — the largest reported positions include ARIEL INVESTMENTS, LLC (US$85.2M), Southpoint Capital Advisors LP (US$74.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XRAY

All XRAY fund holders →

FAQ

How long has ARMISTICE CAPITAL, LLC held XRAY?

ARMISTICE CAPITAL, LLC has disclosed XRAY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is ARMISTICE CAPITAL, LLC's current position in XRAY?

As of Q2 2026, ARMISTICE CAPITAL, LLC holds 3.67M shares of XRAY (DENTSPLY SIRONA INC), valued at $38.96M, representing 0.51% of its reported portfolio and ranking #27.

Has ARMISTICE CAPITAL, LLC been buying or selling XRAY?

In the latest 13F filing (Q2 2026), ARMISTICE CAPITAL, LLC increased its position in XRAY. The position peaked in Q4 2025 at 7.30M shares.

Which other funds hold XRAY?

Other major institutional holders of XRAY include ARIEL INVESTMENTS, LLC, Southpoint Capital Advisors LP, among 13 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.